The movie Extraordinary Measures tells the story of parents who formed a biotechnology company to develop a drug that could save the lives of children who have the rare life-threatening disease known as Pompe.
In the movie, which is based on the book The Cure, Harrison Ford plays research scientist Robert Stonehill, who was instrumental in finding the cure, while Brendan Fraser plays John Crowley, the man who raised US$100 million to buck the medical establishment.
In reality, John Crowley is the name of the person who started the biomedical company, but the real Dr Stonehill who developed the cure is in fact Chen Yuan-tsong (陳垣崇), director of Academia Sinica’s Institute of Biomedical Sciences.
PHOTO: CNA
At an event held earlier this week by the Taiwan Foundation for Rare Disorders to mark the debut in Taiwan of the movie’s DVD, Chen said he had mixed feelings watching the movie.
He said he began researching a cure for Pompe disease in 1991 after being saddened by the deaths of so many children from the affliction.
“Before I knew it, it had been 15 years,” he said. “It also surprised me that Hollywood would have made a motion picture out of it, making it the second movie about rare diseases and patients after Lorenzo’s Oil.”
Movie critic Roger Ebert said that Harrison Ford, as the film’s executive producer, probably saw Stonehill as a good role for himself and ordered a rewrite of the script because he could not play Chen.
Regardless of how Hollywood decided to recast Chen, his contribution to helping find the cure is well established.
He developed the treatment with colleagues at the Duke University Medical Center. His research and development was mostly done in the US, but Chen conducted his clinical trials for the cure — later named Myozyme — at National Taiwan University Hospital.
Myozyme, which took Chen and his team 15 years to research and develop, was introduced in Taiwan by US pharmaceutical company Genzyme and has been covered by the National Health Insurance (NHI) program since 2005, the foundation said.
Myozyme was sold in Europe and the US after it was approved by the US Food and Drug Administration and the EU health authority in 2006. It has contributed to saving the lives of more than 1,000 patients with Pompe disease, or acid maltase deficiency, worldwide each year, including 34 in Taiwan.
Young Pompe disease sufferers have symptoms similar to muscular dystrophy, the foundation said.
Without a cure, most children with Pompe disease die before they reach two years old. There is also a juvenile and adult form of the disease, which can appear at almost any age, the foundation said.
Currently, Pompe disease patients in Taiwan receive NT$7.9 million (US$245,577) per patient per year in Myozyme and related medical care under the NHI program, greatly reducing their families’ financial burden, the foundation said.
The foundation quoted tallies from the Cabinet-level Department of Health as indicating that there are nearly 6,000 families with rare disease patients in Taiwan, but more than 70 percent of them do not receive effective drugs or therapies, the foundation said.
CHANGING LANDSCAPE: Many of the part-time programs for educators were no longer needed, as many teachers obtain a graduate degree before joining the workforce, experts said Taiwanese universities this year canceled 86 programs, Ministry of Education data showed, with educators attributing the closures to the nation’s low birthrate as well as shifting trends. Fifty-three of the shuttered programs were part-time postgraduate degree programs, about 62 percent of the total, the most in the past five years, the data showed. National Taiwan Normal University (NTNU) discontinued the most part-time master’s programs, at 16: chemistry, life science, earth science, physics, fine arts, music, special education, health promotion and health education, educational psychology and counseling, education, design, Chinese as a second language, library and information sciences, mechatronics engineering, history, physical education
The Chinese military has boosted its capability to fight at a high tempo using the element of surprise and new technology, the Ministry of National Defense said in the Quadrennial Defense Review (QDR) published on Monday last week. The ministry highlighted Chinese People’s Liberation Army (PLA) developments showing significant changes in Beijing’s strategy for war on Taiwan. The PLA has made significant headway in building capabilities for all-weather, multi-domain intelligence, surveillance, operational control and a joint air-sea blockade against Taiwan’s lines of communication, it said. The PLA has also improved its capabilities in direct amphibious assault operations aimed at seizing strategically important beaches,
‘MALIGN PURPOSE’: Governments around the world conduct espionage operations, but China’s is different, as its ultimate goal is annexation, a think tank head said Taiwan is facing a growing existential threat from its own people spying for China, experts said, as the government seeks to toughen measures to stop Beijing’s infiltration efforts and deter Taiwanese turncoats. While Beijing and Taipei have been spying on each other for years, experts said that espionage posed a bigger threat to Taiwan due to the risk of a Chinese attack. Taiwan’s intelligence agency said China used “diverse channels and tactics” to infiltrate the nation’s military, government agencies and pro-China organizations. The main targets were retired and active members of the military, persuaded by money, blackmail or pro-China ideology to steal
The High Prosecutors’ Office yesterday withdrew an appeal against the acquittal of a former bank manager 22 years after his death, marking Taiwan’s first instance of prosecutors rendering posthumous justice to a wrongfully convicted defendant. Chu Ching-en (諸慶恩) — formerly a manager at the Taipei branch of BNP Paribas — was in 1999 accused by Weng Mao-chung (翁茂鍾), then-president of Chia Her Industrial Co, of forging a request for a fixed deposit of US$10 million by I-Hwa Industrial Co, a subsidiary of Chia Her, which was used as collateral. Chu was ruled not guilty in the first trial, but was found guilty
RSS